Skip to main navigation Skip to search Skip to main content

Perioperative Dextran-40 Infusion and Early Allograft Outcomes After Adult Liver Transplantation: An Overlap-Weighted Cohort Study

  • Nattaya Raykateeraroj
  • , Dong Kyu Lee
  • , Je Min Albert Suh
  • , Nuanprae Kitisin
  • , Suwandi Dewapura
  • , Rebecca Caragata
  • , Thomas Freeman
  • , Harry Botta
  • , Zoe Yin
  • , Ariane Flinkier
  • , Nghiep Tran
  • , Dharshi Karalapillai
  • , Caleb Fischer
  • , Marcos Perini
  • , Michael Fink
  • , Laurence Weinberg
  • Austin Health
  • Dongguk University Ilsan Hospital
  • Austin Hospital
  • The University of Melbourne
  • Department of Critical Care

Research output: Contribution to journal › Article › peer-review

1 Citation (Scopus)

Abstract

Introduction: Dextran-40 has rheological and antithrombotic effects that could modulate early allograft injury, but contemporary evidence in adults is limited. We evaluated whether early postoperative dextran-40 use was associated with improved graft outcomes. Methods: In this single-center retrospective cohort, we studied 900 adult liver transplant recipients (2009–2023) using a 48-h landmark to reduce immortal-time bias; 883 patients alive with their primary graft at 48 h formed the analytic cohort. Early exposure was defined as starting dextran-40 within 48 h after transplantation versus later or no dextran. Confounding was addressed with propensity score overlap weighting. Primary outcomes were primary nonfunction, early allograft dysfunction, and 30-day graft loss. Results: In the overlap-weighted analyses, early dextran-40 was associated with lower 30-day graft loss (2.0% versus 7.6%; risk difference −5.6 percentage points, 95% confidence interval −10.5 to −0.7). Rates of primary nonfunction, early allograft dysfunction, mortality, thrombotic events, acute kidney injury, and reoperation for bleeding did not differ meaningfully between groups. Conclusions: In this contemporary cohort, early dextran-40 administration was associated with better short-term graft survival without evidence of safety concerns. These observational findings warrant confirmation in prospective multicenter trials.

Original languageEnglish
Pages (from-to)458-470
Number of pages13
JournalJournal of Surgical Research
Volume322
DOIs
Publication statusPublished - Jun 2026

Keywords

  • Dextran
  • Graft survival
  • Liver transplantation
  • Postoperative complications
  • Thrombosis

Fingerprint

Dive into the research topics of 'Perioperative Dextran-40 Infusion and Early Allograft Outcomes After Adult Liver Transplantation: An Overlap-Weighted Cohort Study'. Together they form a unique fingerprint.

Cite this